CME
Income statement / Annual
Last year (2023), CME Group Inc.'s total revenue was $5.58 B,
an increase of 11.15% from the previous year.
In 2023, CME Group Inc.'s net income was $3.23 B.
See CME Group Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$5.58 B
|
$5.02 B
|
$4.69 B
|
$4.88 B
|
$4.87 B
|
$4.31 B
|
$3.64 B
|
$3.60 B
|
$3.33 B
|
$3.11 B
|
| Cost of Revenue |
$1.04 B |
$753.10 M |
$837.00 M |
$856.50 M |
$898.70 M |
$672.20 M |
$586.80 M |
$567.80 M |
$581.50 M |
$584.10 M |
| Gross Profit |
$4.54 B |
$4.27 B |
$3.85 B |
$4.03 B |
$3.97 B |
$3.64 B |
$3.06 B |
$3.03 B |
$2.75 B |
$2.53 B |
| Gross Profit Ratio |
0.81 |
0.85 |
0.82 |
0.82 |
0.82 |
0.84 |
0.84 |
0.84 |
0.83 |
0.81 |
| Research and Development
Expenses |
$0.00
|
$188.60 M
|
$192.60 M
|
$198.50 M
|
$201.50 M
|
$117.20 M
|
$101.60 M
|
$97.60 M
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$144.40 M
|
$137.40 M
|
$151.70 M
|
$191.30 M
|
$174.10 M
|
$453.90 M
|
$421.40 M
|
$437.70 M
|
$403.60 M
|
$398.20 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$144.40 M
|
$137.40 M
|
$151.70 M
|
$191.30 M
|
$174.10 M
|
$453.90 M
|
$421.40 M
|
$437.70 M
|
$403.60 M
|
$398.20 M
|
| Other Expenses |
$960.30 M |
$1.11 B |
$1.06 B |
$1.20 B |
$1.21 B |
$575.70 M |
$324.50 M |
$387.00 M |
$353.00 M |
$361.80 M |
| Operating Expenses |
$1.10 B |
$1.25 B |
$1.21 B |
$1.39 B |
$1.38 B |
$1.03 B |
$745.90 M |
$824.70 M |
$756.60 M |
$760.00 M |
| Cost And Expenses |
$2.14 B |
$2.00 B |
$2.04 B |
$2.25 B |
$2.28 B |
$1.70 B |
$1.33 B |
$1.39 B |
$1.34 B |
$1.34 B |
| Interest Income |
$0.00 |
$2.20 B |
$306.90 M |
$182.70 M |
$626.80 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$159.40 M |
$162.70 M |
$166.90 M |
$166.20 M |
$178.00 M |
$157.70 M |
$117.00 M |
$123.50 M |
$117.40 M |
$119.40 M |
| Depreciation &
Amortization |
$352.60 M
|
$2.00 B
|
$2.04 B
|
$2.25 B
|
$2.28 B
|
$1.76 B
|
$1.33 B
|
$1.49 B
|
$129.20 M
|
$132.60 M
|
| EBITDA |
$3.79 B
|
$3.37 B
|
$2.99 B
|
$3.14 B
|
$3.13 B
|
$2.93 B
|
$2.51 B
|
$2.45 B
|
$2.23 B
|
$2.02 B
|
| EBITDA Ratio |
0.68 |
0.63 |
0.6 |
0.57 |
0.56 |
0.63 |
0.67 |
0.65 |
0.64 |
0.61 |
| Operating Income Ratio
|
0.62
|
0.6
|
0.56
|
0.54
|
0.53
|
0.61
|
0.63
|
0.61
|
0.6
|
0.57
|
| Total Other
Income/Expenses Net |
$717.90 M
|
$474.40 M
|
$728.40 M
|
$84.70 M
|
$101.80 M
|
$170.20 M
|
$215.70 M
|
$87.10 M
|
-$31.90 M
|
$3.00 M
|
| Income Before Tax |
$4.15 B |
$3.49 B |
$3.37 B |
$2.72 B |
$2.69 B |
$2.78 B |
$2.53 B |
$2.29 B |
$1.96 B |
$1.77 B |
| Income Before Tax Ratio
|
0.74
|
0.7
|
0.72
|
0.56
|
0.55
|
0.64
|
0.69
|
0.64
|
0.59
|
0.57
|
| Income Tax Expense |
$927.40 M |
$799.30 M |
$736.70 M |
$615.70 M |
$573.80 M |
$814.10 M |
-$1.54 B |
$753.50 M |
$709.80 M |
$644.50 M |
| Net Income |
$3.23 B |
$2.69 B |
$2.64 B |
$2.11 B |
$2.12 B |
$1.96 B |
$4.06 B |
$1.53 B |
$1.25 B |
$1.13 B |
| Net Income Ratio |
0.58 |
0.54 |
0.56 |
0.43 |
0.43 |
0.46 |
1.11 |
0.43 |
0.37 |
0.36 |
| EPS |
8.87 |
7.41 |
7.3 |
5.88 |
5.93 |
5.73 |
12 |
4.55 |
3.71 |
3.37 |
| EPS Diluted |
8.86 |
7.4 |
7.29 |
5.87 |
5.91 |
5.71 |
11.94 |
4.53 |
3.69 |
3.35 |
| Weighted Average Shares
Out |
$359.02 M
|
$358.71 M
|
$358.34 M
|
$357.76 M
|
$357.16 M
|
$342.34 M
|
$338.71 M
|
$337.50 M
|
$336.22 M
|
$334.41 M
|
| Weighted Average Shares
Out Diluted |
$359.50 M
|
$359.18 M
|
$358.93 M
|
$358.52 M
|
$358.24 M
|
$343.74 M
|
$340.23 M
|
$338.97 M
|
$337.89 M
|
$336.06 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
